Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.

Worni M, Akushevich I, Gloor B, Scarborough J, Chino JP, Jacobs DO, Hahn SM, Clary BM, Pietrobon R, Shah A.

Ann Surg Oncol. 2012 Apr;19(4):1316-23. doi: 10.1245/s10434-011-2088-2. Epub 2011 Oct 15.

PMID:
22002799
2.

Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.

Swartz MJ, Hsu CC, Pawlik TM, Winter J, Hruban RH, Guler M, Schulick RD, Cameron JL, Laheru DA, Wolfgang CL, Herman JM.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):839-44. doi: 10.1016/j.ijrobp.2009.02.071. Epub 2009 Aug 3.

3.

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.

Pancreas. 2008 Jan;36(1):50-5. doi: 10.1097/MPA.0b013e31812575df.

PMID:
18192881
4.

Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.

Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, Chen JH, Yiannoutsos CT, Lillemoe KD, Farnell MB, Sarr MG, Schmidt CM.

J Am Coll Surg. 2011 Aug;213(2):275-83. doi: 10.1016/j.jamcollsurg.2011.04.003. Epub 2011 May 20.

PMID:
21601488
5.

Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.

Wasif N, Bentrem DJ, Farrell JJ, Ko CY, Hines OJ, Reber HA, Tomlinson JS.

Cancer. 2010 Jul 15;116(14):3369-77. doi: 10.1002/cncr.25070.

6.

Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma.

Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Tanizawa Y.

Hepatogastroenterology. 2007 Mar;54(74):564-9.

PMID:
17523323
7.

Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.

Ceppa EP, Roch AM, Cioffi JL, Sharma N, Easler JJ, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM.

Surgery. 2015 Oct;158(4):937-44; discussion 944-5. doi: 10.1016/j.surg.2015.06.003. Epub 2015 Jul 11.

PMID:
26173683
8.

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.

Gut. 2002 Nov;51(5):717-22.

9.

Invasive IPMN and MCN: same organ, different outcomes?

Kargozaran H, Vu V, Ray P, Bagaria S, Steen S, Ye X, Gagandeep S.

Ann Surg Oncol. 2011 Feb;18(2):345-51. doi: 10.1245/s10434-010-1309-4. Epub 2010 Aug 31.

PMID:
20809175
10.

A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.

McDade TP, Hill JS, Simons JP, Piperdi B, Ng SC, Zhou Z, Kadish SP, Fitzgerald TJ, Tseng JF.

Cancer. 2010 Jul 1;116(13):3257-66. doi: 10.1002/cncr.25069.

11.

Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.

Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N.

Am J Surg Pathol. 2008 Feb;32(2):243-55. doi: 10.1097/PAS.0b013e3181484f1e.

PMID:
18223327
12.

Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.

Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.

Ann Surg Oncol. 2007 Nov;14(11):3174-80. Epub 2007 Aug 12.

PMID:
17694416
13.

Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy.

Turrini O, Waters JA, Schnelldorfer T, Lillemoe KD, Yiannoutsos CT, Farnell MB, Sarr MG, Schmidt CM.

HPB (Oxford). 2010 Sep;12(7):447-55. doi: 10.1111/j.1477-2574.2010.00196.x.

14.

Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T.

J Surg Oncol. 2009 Jul 1;100(1):13-8. doi: 10.1002/jso.21290.

PMID:
19384908
15.

Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.

Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB.

Ann Surg Oncol. 2006 Apr;13(4):582-94. Epub 2006 Mar 7.

PMID:
16523362
16.

Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas.

Poultsides GA, Reddy S, Cameron JL, Hruban RH, Pawlik TM, Ahuja N, Jain A, Edil BH, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL.

Ann Surg. 2010 Mar;251(3):470-6. doi: 10.1097/SLA.0b013e3181cf8a19.

17.

Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas.

Murakami Y, Uemura K, Hayashidani Y, Sudo T, Sueda T.

J Gastrointest Surg. 2007 Mar;11(3):338-44.

PMID:
17458608
18.

Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.

Hwang DW, Jang JY, Lee SE, Lim CS, Lee KU, Kim SW.

Langenbecks Arch Surg. 2012 Jan;397(1):93-102. doi: 10.1007/s00423-010-0674-6. Epub 2010 Jul 18.

PMID:
20640860
19.

Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.

Nakagohri T, Konishi M, Inoue K, Tanizawa Y, Kinoshita T.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1480-3.

PMID:
15362782
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk